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Abstract
Introduction: Specimen adequacy is a crucial preanalytical factor affecting accuracy and usefulness of test result. The aim of this study was to 
determine the frequency and reasons for rejected haematology specimens, preanalytical variables which may affect specimen quality, and consequ-
ences of rejection, and provide suggestions on monitoring quality indicators as to obtain a quality improvement.
Materials and methods: A cross-sectional survey was conducted and a questionnaire was sent to 1586 laboratories. Participants were asked to 
provide general information about institution and practices on specimen management and record rejections and reasons for rejection from 1st to 
31st July. 
Results: A total survey response rate was 56% (890/1586). Of 10,181,036 tubes received during the data collection period, 11,447 (0.11%) were 
rejected, and the sigma (σ) was 4.6. The main reason for unacceptable specimens was clotted specimen (57%). Rejected specimens were related 
to source department, container type, container material type, transportation method and phlebotomy personnel. The recollection of 84% of the 
rejected specimens was required. The median specimen processing delay in inpatient, outpatient and emergency department were 81.0 minutes, 
57.0 minutes and 43.3 minutes, respectively. 
Conclusions: Overall, rejection rate was a slightly lower than previously published data. In order to achieve a better quality in the preanalytical 
phase, haematology laboratories in China should pay more attention on training for phlebotomy and sample transportation, identify main reasons 
for clotted specimen and take effective measures. The platform in the study will be helpful for long-term monitoring, but simplification and modifi-
cation should be introduced in the following investigation.
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Although laboratory medicine seems overall less 
vulnerable to mistakes and violations than other 
clinical and diagnostic areas, the chance of errors 
is still not negligible and may generate adverse 
consequences on both the quality of testing and 
patient safety (1). For errors in total testing process 
(TTP), preanalytical errors have been found at the 
majority of the total errors (46 - 68%) in laboratory 
medicine, mainly emerging from manually inten-
sive activities, especially those related to collec-
tion, handling, transportation, preparation and 
storage of diagnostic specimens. Less errors occur 
in the analytical (7 - 13%) and postanalytical (18 - 
47%) phase (1,2). Specimen adequacy is a crucial 
preanalytical factor affecting the accuracy and 
usefulness of test result (3). Laboratories usually 
establish a guideline for evaluating the acceptance 
of submitted specimens, and specimens not meet-
ing the criteria of acceptability are rejected. Data 
on rejected samples due to various types of pre-
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analytical errors are one of laboratory medicine 
preanalytical quality indicators (4). 
Many agencies have developed surveys on speci-
men acceptability. The College of American Pa-
thologists (CAP) Q-Probes analysis determined the 
frequency and reasons for rejection of chemistry 
specimens and complete blood count specimens 
and quantified the clinical consequences of speci-
men rejection (3,5,6). A retrospective analysis of 
the preanalytical phase had been carried out in 
Spain (7). In addition, several papers have been 
published concerning preanalytical errors and re-
jected specimens among different laboratories 
(4,8,9). 
Preanalytical errors start to occur at the point of 
entry for laboratory test requests by clinicians (4). 
Studies showed that the main rejection reasons 
for haematology specimens were clotted samples 
and insufficient specimen quantity (5,10). Personal 
impact on specimen collection was an important 
factor and the preanalytical error rate was 2 to 4 
times higher for non-laboratory phlebotomists 
than laboratory staff (4). 
An investigation on specimen acceptability for 
complete blood count testing and coagulation 
testing was conducted in 2012, but it was just a 
general preliminary survey (11). In the past 5 years, 
more attention has been paid on preanalytical 
phase and laboratory information system (LIS) was 
continuously optimized. It called the need to know 
the present situation of preanalytical haematology 
specimen acceptability in China. The aim of this 
study was to determine the frequency and rea-
sons for rejected haematology specimens, identify 
preanalytical variables which may affect specimen 
quality and consequences of rejection, and pro-
vide suggestions on monitoring quality indicators.
Materials and methods
Study design
A cross-sectional survey on specimen acceptabili-
ty was initiated by the National Center for Clinical 
Laboratories (NCCL) in China and the study was 
conducted as part of the regular external quality 
assessment (EQA) scheme for 2017. Clinical labora-
tories participating in EQA programmes of clinical 
haematology were enrolled in this study, exclud-
ing non-hospital laboratories, such as commercial 
laboratories, centers for disease control and pre-
vention, blood donation and supply institutions. A 
web-based questionnaire and survey notice were 
sent online on June 15th 2017, along with that, a 
short message was sent to laboratory directors ex-
plaining the purpose of the study. Participants 
were asked to give a response before 31th August 
and all data were collected via special software 
designed by NCCL and developed by CLInet Infor-
mation Technology (Beijing, China). 
Survey
The questionnaire was divided into two parts. The 
first part contained 18 questions on institution 
characteristics and laboratory practices on collec-
tion, transportation, and specimen handling. The 
second part comprised information about haema-
tology specimen acceptability. In this part, partici-
pants were asked to register all specimens submit-
ted to the laboratory for haematology testing 
which were determined to be rejected from 1st to 
31th July. For each rejected specimen, the follow-
ing information had to be recorded: source de-
partment, container type, container material type, 
transportation method, phlebotomy personnel, 
reason for rejection, action taken and time (includ-
ing time of specimen receipt, time of specimen re-
jection and time of specimen recollected or rela-
belled). The above information was selected from 
a drop menu. Furthermore, participants also pro-
vided the total number of haematology speci-
mens (both acceptable for testing and rejected) 
submitted in the same time period and the total 
number of specimens by source department, con-
tainer type, container material type, transporta-
tion method and phlebotomy personnel.
Laboratories which provided questionnaires with-
out the total number of specimens submitted or 
with incomplete data were excluded. Further-
more, laboratories which registered not only hae-
matology specimens but also specimens of other 
branches (such as chemistry or immunology), were 
not included in the analysis. 
https://doi.org/10.11613/BM.2018.030704 Biochem Med (Zagreb) 2018;28(3):030704 
  3
Ye Y. et al.  Haematology specimen acceptability in China
Statistical analysis
Excel (Microsoft, Redmond, WA) (2007 version) and 
SPSS 20.0 (IBM SPSS Inc., Chicago, USA) were used 
to analyse collected data. The overall rejection rate 
and interlaboratory rejection rate were calculated 
by the number of rejected specimens per total 
specimens. Percentage (%) and sigma value (σ) 
were employed to evaluate the status of rejection 
rate and data were presented as percentiles (p5, 
p25, p50, p75, p95) of distribution. The characteris-
tics and practices of institutions were considered 
and participants were grouped according to them. 
The data of submitted and rejected specimens 
were aggregated and the Odds ratio (OR) was cal-
culated, for each level, by dividing the percentage 
of rejected specimen by the baseline percentage 
of rejected specimen. The OR and their associated 
95% confidence intervals (CI) were calculated, and 
it was considered to be statistically significant if 
the associated 95% CI didn’t include the value 1.00. 
Besides, specimen processing delay, defined as 
the interval between the original and recollected/
relabelled specimen receipt time, was calculated. 
Shapiro-Wilks (N ≤ 50) and Kolmogorov-Smirnov 
modified by Lilliefors (N＞50) were used to test the 
normality of the data. Nonparametric Kruskal-Wal-
lis test for three or more groups and the Mann-
Whitney U test for two groups were performed to 
compare the interlaboratory rejection rate by fea-
tures of institutions and the specimen processing 
delay in different departments. Significance was 
defined as probability, P-value＜0.05. 
Results
A total of 1586 questionnaires were sent, among 
which, 890 questionnaires were returned, giving a 
response rate of 56% (890/1586). According to ex-
clusion criteria, 580 questionnaires were consid-
ered valid and included in further analysis. Out of 
these, tertiary hospital accounted for 77%, with 
only 1.2% were accredited by CAP and 11% by ISO 
15189. Most of participants (69%) were general 
hospitals and 15% were specialized hospitals (Ta-
ble 1). 
Table 1. Questions and answers delivered to participants
Questions and possible answers Number of laboratories, N (%)
1. What grade does your hospital belong to?
A. Class III Grade I 342 (59.0)
B. Class III Grade II 103 (17.7)
C. Under Class II 135 (23.3)
2. What category does your hospital belong to?
A. General hospital 400 (69.0)
B. Specialized hospital 87 (15.0)
C. Traditional Chinese and western medicine hospital 16 (2.8)
D. Traditional Chinese medicine hospital 46 (7.9)
E. Maternal and child-care service centers 26 (4.5)
F. Others 5 (0.8)
3. How many beds does your laboratory occupy?
A. 0 - 500 136 (23.4)
B. 501 - 1000 204 (35.2)
C. 1001 - 1500 128 (22.1)
D. more than 1500 112 (19.3)
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4. Is your laboratory accredited by CAP?
A. Yes 7 (1.2)
B. No 573 (98.8)
5. Is your laboratory accredited by ISO 15189?
A. Yes 64 (11.0)
B. No 516 (89.0)
6. What is the most common phlebotomy personnel in inpatient department of your hospital?
A. Nurse (managed by nursing department) 560 (96.5)
B. Nurse (managed by clinical laboratory) 9 (1.6)
C. Laboratory personnel 3 (0.5)
D. Clinician 3 (0.5)
E. Others 5 (0.9)
7. What is the most common phlebotomy personnel in outpatient department of your hospital?
A. Nurse (managed by nursing department) 227 (39.1)
B. Nurse (managed by clinical laboratory) 149 (25.7)
C. Laboratory personnel 195 (33.6)
D. Others 9 (1.6)
8. What is the most common phlebotomy personnel in emergency department of your hospital?
A. Nurse (managed by nursing department) 418 (72.1)
B. Nurse (managed by clinical laboratory) 38 (6.6)
C. Laboratory personnel 111 (19.1)
D. Others 13 (2.2)
9. What is the most common way of specimen transportation for inpatient department of your hospital?
A. Laboratory personnel 27 (4.7)
B. Pneumatic tube system 31 (5.3)
C. Full-time transportation worker 390 (67.2)
D. Nurse 71 (12.2)
E. Patient or relation 4 (0.7)
F. Company 48 (8.3)
G. Others 9 (1.6)
10. What is the most common way of specimen transportation in outpatient department of your hospital?
A. Laboratory personnel 256 (44.2)
B. Pneumatic tube system 17 (2.9)
C. Full-time transportation worker 188 (32.4)
D. Nurse 65 (11.2)
E. Patient or relation 25 (4.3)
F. Company 23 (4.0)
G. Others 6 (1.0)
11. What is the most common way of specimen transportation in emergency department of your hospital?
A. Laboratory personnel 44 (7.6)
B. Pneumatic tube system 23 (4.0)
C. Full-time transportation worker 261 (45.0)
Table 1. (Continued)
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D. Nurse 125 (21.6)
E. Patient or relation 86 (14.8)
F. Company 31 (5.3)
G. Others 10 (1.7)
12. What’s the training frequency for venous blood collection in your hospital?
A. Once a year 218 (37.6)
B. Once halt a year 94 (16.2)
C. Once every 1 to 3 months 50 (8.6)
D. Irregularly 202 (34.8)
E. Others 16 (2.8)
13. Does your laboratory establish a specimen rejection criterion?
A. Yes 571 (98.4)
B. No 9 (1.6)
14. Does your laboratory routinely review main reasons for specimen rejection and take measures on it?
A. Yes 505 (87.1)
B. No 75 (12.9)
15. Does your laboratory monitor time from phlebotomy to specimen admission for tubes sampled outside of 
laboratory?
A. Yes 369 (63.6)
B. No 211 (36.4)
16. Does your laboratory monitor temperature conditions for tubes sampled outside of laboratory?
A. Yes 112 (19.3)
B. No 468 (80.7)
17. How does your laboratory record the rejected specimens?
A. Record on paper 263 (45.3)
B. Record in the computer system 141 (24.3)
C. Both record on paper and in the computer system 165 (28.5)
D. Do not record 3 (0.5)
E. Other 8 (1.4)
18. What actions does your laboratory take when reporting a rejected specimen?
A. Explain the reason why the specimen is rejected and returned 24 (4.1)
B. Explain the reason why the specimen is rejected and returned, and request to recollect 242 (41.7)
C. Do not return the specimen, but explain the reason why the specimen is rejected 5 (0.9)
D. Do not return the specimen, but explain the reason why the specimen is rejected, and 
request to recollect 306 (52.8)
E. Other 3 (0.5)
ISO - International Organization for Standardization. CAP - College of American Pathologists.
Nurse managed by nursing department was the 
most frequent phlebotomy personnel in inpatient 
department (97%) and emergency department 
(72%). As for outpatient department, the common 
phlebotomy personnel were nurse managed by 
nursing department (39%), laboratory personnel 
(34%) and nurse managed by clinical laboratory 
(26%). Common specimen transportation meth-
ods were by full-time transportation worker (67%) 
and nurse (12%) in inpatient department; full-time 
Table 1. (Continued)
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transportation worker (32%) and laboratory per-
sonnel (44%) in outpatient department; full-time 
transportation worker (45%) and nurse (22%) in 
emergency department. The proportion of partici-
pants using a pneumatic tube system for transpor-
tation in the three departments were 5%, 3% and 
4%, respectively. Table 1 summarizes all the re-
sponses received from participants in the ques-
tionnaire. 
Out of 10,181,036 reported haematology speci-
mens submitted to the participating laboratories, 
11,447 (0.11%) were rejected, and the σ of the over-
all rejection rate was 4.6. The distribution of per-
centiles of the rejection rate (% and σ) were as fol-
lows: the 5th, 25th ,50th ,75th and 95th for percent-
age was 0.01%, 0.04%, 0.09%, 0.18% and 0.50%, 
and for σ scale was 4.1, 4.4, 4.6, 4.9 and 5.2, respec-
tively. Figure 1 shows the distribution of partici-
pating laboratories according to the percentage 
and σ scale of haematology specimens rejected. A 
total of 311, 137 and 55 laboratories, respectively, 
provided a rejection rate lower than 0.1%, be-
tween 0.1% and 0.2%, and between 0.2% and 
0.3%. Most of laboratories (82%) had a σ between 
4σ and 5σ. 
Table 2 illustrates the specimen rejection rate of 
participants according to their characteristics/
practices, including hospital grade, bed size, ISO 
15189/CAP accreditation, training frequency for 
phlebotomy personnel, specimen rejection crite-
ria, and periodically reviewed main reasons for re-
jection and take measures. No significant differ-
ences were identified.
Table 3 compares the percentage of collected and 
rejected specimens according to specimen char-
acteristics, including source department, contain-
er type, container material type, transportation 
method and phlebotomy personnel. Odds ratio 
and 95% CI limits are presented in the last column 
in Table 3.
When compared with source department, 87% of 
rejection specimens were from inpatient depart-
ment, with a rejection rate of 0.19%, which was 
significantly higher than emergency department. 
The OR demonstrated that non-vacuum tube had 
a significantly greater rejection rate than vacuum 
tube. The OR between plastic and glass was 1.13, 
which showed statistical significance, but this ap-
peared to be of little practical significance. Taking 
transportation method into account, transporta-
tion by a full-time transportation worker had a 
slightly higher rejection rate than other methods, 
among which, specimens transported by labora-
tory personnel showed an apparently lower rejec-
tion rate, where the OR was 0.19. As for phleboto-
my personnel, the OR revealed a significantly low-
er rate of rejection for specimens drawn by labora-
tory personnel (0.06) and nurse managed by clini-
cal laboratory (0.13) when compared to nurse 
managed by nursing department, and specimens 
drawn by clinicians had a little higher rejection 
rate than that of nursing staff. 
Table 4 illustrates the distribution of rejected spec-
imens in this study based on reasons for rejection. 
In total, about 85% of rejections attributed to the 
five reasons: specimen clotted (57%), insufficient 
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Institution characteristics/practices N Median of specimen rejection rate, % P
Hospital grade
Class III Grade I 342 0.10
0.200Class III Grade II 103 0.07
Under Class II 135 0.08
Bed size
0 - 500 136 0.10
0.508
501 - 1000 204 0.09
1001 - 1500 128 0.09






Once a year 218 0.10
0.513
Once half a year 94 0.08
Once every one to three months 50 0.09










Training frequency - training frequency for phlebotomy personnel (question 12 in Table 1). Rejection criteria - refer to question 13 
in in Table 1. Periodical rejection summary - refers to the periodical review of main reasons for specimen rejection (question 14 in 
Table 1). ISO - International Organization for Standardization. CAP - College of American Pathologists. Data were analysed using 
Kruskal-and Mann-Whitney U test. P-value ＜ 0.05 was considered statistically significant.
Table 2. Specimen rejection rate by institution characteristics/practices
Specimen characteristic Total specimens, N Rejected specimens, N (%) Rejection rate, % OR (95% CI)
Department
Inpatient 5,155,339 9983 (87.2) 0.19 baseline
Outpatient 3,894,495 761 (6.7) 0.02 0.10 (0.09 - 0.11)
Emergency 1,131,202 703 (6.1) 0.06 0.32 (0.30 - 0.35)
Container type
Vacuum tube 10,114,926 11,330 (99.0) 0.11 baseline
Non-vacuum tube (syringe) 66,110 117 (1.0) 0.18 1.16 (1.32 - 1.90)
Container material type
Plastic 7,329,735 7944 (69.4) 0.11 baseline
Glass 2,851,301 3503 (30.6) 0.12 1.13 (1.09 - 1.18)
Transportation method
Full-time worker 6,245,398 8843 (77.3) 0.14 baseline
Pneumatic tube system 761,618 959 (8.4) 0.13 0.89 (0.83 - 0.95)
Nurse 856,992 906 (7.9) 0.11 0.75 (0.70 - 0.80)
Table 3. Relation between specimen characteristics and specimen collection/rejection
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Laboratory personnel 2,040,421 539 (4.7) 0.03 0.19 (0.17 - 0.20)
Patient or relation 220,408 175 (1.5) 0.08 0.56 (0.48 - 0.65)
Other 56,199 25 (0.2) 0.04 -
Phlebotomy personnel
Nurse A 7,354,885 10,979 (95.9) 0.15 baseline
Nurse B 1,329,202 263 (2.3) 0.02 0.13 (0.12 - 0.15)
Laboratory personnel 1,466,568 139 (1.2) 0.01 0.06 (0.05 - 0.08)
Clinician 13,406 40 (0.4) 0.30 2.00 (1.47 - 2.73)
Other 16,975 26 (0.2) 0.15 -
Nurse A - managed by nursing department. Nurse B - managed by clinical laboratory. OR - odds ratio. CI - confidence interval.
OR was calculated by dividing the percentage of rejected specimen by the baseline of rejected specimen.
Reason for rejection Number of specimens,  N (%)
Specimen clotted 6548 (57.2)
Insufficient specimen volume 1602 (14.0)
Inappropriate specimen-anticoagulant 
volume ratio 791 (6.9)
Incorrect container type 476 (4.2)
Inadequately labelled 326 (2.9)
Specimen haemolysed 306 (2.7)
Lipemia 262 (2.3)
Empty tube 177 (1.6)
Incorrect specimen type 144 (1.3)
Inappropriate time in specimen 
collection 133 (1.2)
Inappropriate test request 121 (1.1)
Payment related 104 (0.9)
Medical orders modified 94 (0.8)
Excessive transportation time 60 (0.5)
Specimen collected on the same side of 
infusion 47 (0.4)
Specimen not received 19 (0.2)
Testing parameters beyond the scope of 
haematology laboratory 18 (0.2)
Inappropriate transportation condition 7 (0.1)
Other reasons 212 (1.9)
Table 4. Reasons for haematology specimen rejection 
specimen volume (14%), inappropriate specimen-
anticoagulant volume ratio (6.9%), incorrect con-
tainer type (4.2%) and inadequately labelled 
(2.9%). 
Of the 11,447 rejected specimens, laboratory staff 
were unable to obtain information about meas-
ures taken of 562 (4.9%) specimens, requested 
9563 (83.6%) specimens to be recollected, and 
asked for 479 (4.2%) specimens to be relabelled, 
and 2.6% rejected specimens were abandoned by 
the laboratory and provider. Besides, 541 (4.7%) re-
jection were classified as “other”, which partici-
pants did not believe fit into one of the provided 
actions. 
Table 5 shows that the median specimen process-
ing delay was statistically significant among differ-
ent source department. The overall median speci-
men processing delay due to specimen rejection 
was 57.0 minutes for outpatient specimens, 43.3 
minutes for emergency specimens and 81.0 min-
utes for inpatient specimens. The result indicated 
that the median specimen processing delay in in-
patient department was greater than which in 
outpatient department (P ＜ 0.001) and emergen-
cy department (P ＜ 0.001), whereas there was no 
significance between outpatient department and 
emergency department (P = 0.111). 
Table 3. (Continued)
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Outpatient 177 9.0 25.0 57.0 106.3 1273.2
＜ 0.001Emergency 136 10.0 25.0 43.3 80.3 191.8
Inpatient 430 21.8 49.4 81.0 125.6 977.3
P5 - 5th percentile. P25 - 25th percentile. P50 - 50th percentile. P75 - 75th percentile. P95 - 95th percentile. Kruskal-Wallis test was used for 
data analysis. P ≤ 0.05 was considered statistically significant.
Table 5. Median specimen processing delay in the three departments investigated
Discussion
The rejection rate in the study was similar to, but 
slightly lower than that found in the previous com-
plete blood count testing study in 2012 (11). The 
comparison, to some extent, illustrates that labo-
ratories in China pay more attention to collection 
and reception of specimens in the past 5 years, 
leading to a reduction in rejection due to preana-
lytical errors. However, it is worth mentioning that 
the apparently good sigma values in the study 
should not mislead laboratories and oversight 
bodies to believe that there were no issues to ad-
dress in preanalytical quality.
Compared with the survey conducted by CAP and 
in Spain, the overall rejection rate in this study was 
much lower, which might be attributed to the fol-
lowing reasons (3,5,7). First, participants in the sur-
vey were mainly tertiary hospitals, which repre-
sents a relatively good laboratory practice in Chi-
na. Second, LIS in some laboratories had no ade-
quate function to record all the information of 
specimens. A lot of participants responded that 
they recorded rejected specimens manually and 
some of them believed that not all the rejected 
specimens were recorded. Third, the definition of 
unacceptable specimen varied among different 
laboratories and laboratories had different rejec-
tion criteria. That means, the same type specimen 
might be rejected by the laboratory but might not 
be rejected by the other laboratory. 
The most common rejection reason was clotted 
specimen, which occurred four times more often 
than the second most common reason for rejec-
tion, insufficient specimen volume. The result was 
similar to the study of haematology specimen ac-
ceptability conducted by CAP, whose most com-
mon reasons for rejection was clotted and insuffi-
cient specimen quantity (5). Since the predomi-
nance of clotted specimens, participants were 
suggested to have an in-depth investigation for 
reasons for that. For example, the blood collection 
procedure and the mixing procedure of collection 
tube, so as to decrease the occurrence of clotted 
specimen. 
It is worth mentioning that transportation method 
and phlebotomy personnel were important influ-
ence factors for specimen acceptability. Speci-
mens transported by laboratory personnel and 
specimens collected by laboratory personnel and 
nurse managed by laboratory exhibited a much 
lower rejection rate. It possibly because laboratory 
personnel had a better knowledge of the influ-
ence factors of specimen and had a better practice 
on specimen collection and transportation. The 
results mean that participants might benefit from 
strengthening training for phlebotomy and trans-
portation personnel.
The common direct consequences of specimen re-
jection were the need to recollect a new specimen 
and result in delay in the examination and report-
ing of the specimen. The outcomes of specimen 
recollection and delay in reporting usually led to 
patient complaint and dissatisfaction and post-
poned the diagnosis and treatment for the pa-
tient. 
A survey on specimen acceptability in China was 
conducted in 2012 (11). However, considering it 
was an initial investigation on quality indicators 
conducted by NCCL in China, the content of the in-
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vestigation and the data returned was not com-
plete. Compared to that, this study had a detailed 
investigation on the practice of the management 
in preanalytical phase and had a detailed analysis 
on the relation between specimen acceptability 
and specimen characteristics and quantified the 
consequence of specimen processing delay. How-
ever, there was certain limitation in the study. Par-
ticipants were asked to register all the information 
of rejected specimens, one by one, which was a lit-
tle complicated and hard to complete.
In summary, the management of unacceptable 
specimens in China needs to be improved. The cri-
teria for specimen rejection and judgment meth-
od for unacceptable specimens need to be harmo-
nized. Specimen rejection rate was an important 
indicator for quality monitoring in preanalytical 
phase. Laboratories themselves should regularly 
review the monthly specimen rejection rate and 
related influence factor and take effective actions. 
Strengthening information system construction 
played a key role in the process. The main objec-
tive of EQA program for specimen acceptability 
was to provide a useful tool for laboratories to bet-
ter follow up the status and achieved the quality 
continuous improvement. The platform and 
framework for specimen acceptability in the study 
would be helpful for long-term monitoring of 
quality indicators for clinical laboratories, but the 
questionnaire in this study was a little complicat-
ed. In order to have a more convenient and correct 
fill in of answer forms, simplification and modifica-
tion should be introduced in the following investi-
gation. 
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